RenovoRx Inc (RNXT)
1.243
+0.03
(+2.73%)
USD |
NASDAQ |
Apr 26, 16:00
1.28
+0.04
(+2.98%)
After-Hours: 20:00
RenovoRx Total Assets (Quarterly): 1.466M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.466M |
| September 30, 2023 | 3.519M |
| June 30, 2023 | 6.314M |
| March 31, 2023 | 4.561M |
| December 31, 2022 | 7.265M |
| September 30, 2022 | 9.25M |
| June 30, 2022 | 11.24M |
| Date | Value |
|---|---|
| March 31, 2022 | 13.95M |
| December 31, 2021 | 16.29M |
| September 30, 2021 | 18.18M |
| June 30, 2021 | 2.164M |
| March 31, 2021 | 1.278M |
| December 31, 2020 | 1.914M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.278M
Minimum
Mar 2021
18.18M
Maximum
Sep 2021
7.491M
Average
6.314M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Annexon Inc | 297.67M |
| Longeveron Inc | 12.08M |
| MiNK Therapeutics Inc | 4.552M |
| Adlai Nortye Ltd | 66.50M |
| Telomir Pharmaceuticals Inc | 4.774M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.466M |
| Shareholders Equity (Quarterly) | -3.00M |